• To compare the effectiveness of robot-assisted and standard laparoscopic prostatectomy.
Objective
• To compare the effectiveness of robot-assisted and standard laparoscopic prostatectomy.
Methods
• A care pathway was described.
• We performed a systematic literature review based on a search of Medline, Medline in Process, Embase, Biosis, Science Citation Index, Cochrane Controlled Trials Register, Current Controlled Trials, Clinical Trials, WHO International Clinical Trials Registry and NIH Reporter, the Health Technology Assessment databases, the Database of Abstracts of Reviews of Effects, and relevant conference abstracts up to 31st October 2010). Additionally, reference lists were scanned, an expert panel consulted, and websites of manufacturers, professional organisations, and regulatory bodies were checked.
• We selected randomised controlled trials (RCTs) and non-randomised comparative studies, published after 1st January 1995, including men with localised prostate cancer undergoing robot-assisted or laparoscopic prostatectomy compared with the other procedure or with open prostatectomy. Studies where at least 90% of included men had clinical tumour stages T1 to T2 and which reported at least one of our specified outcomes were eligible for inclusion.
• A mixed-treatment comparison meta-analysis was performed to generate comparative statistics on specified outcomes.
Results
• We included data from 19 064 men across one RCT and 57 non-randomised comparative reports. 
Conclusions
• Men undergoing robotic prostatectomy appear to have reduced surgical morbidity, and a lower risk of a positive surgical margin, which may reduce rates of cancer recurrence and the need for further treatment, but considerable uncertainty surrounds these results.
• We found no evidence that men undergoing robotic prostatectomy are disadvantaged in terms of early outcomes.
• We were unable to determine longer-term relative effectiveness.
Introduction
Radical prostatectomy performed using open or minimally invasive techniques is the preferred treatment option for men diagnosed with localised prostate cancer with ∼88 000 procedures carried out in the USA in 2008 [1] and 5500 in the UK in 2012 [2] . Surgical innovation to reduce blood loss and hasten recovery led to the introduction of firstly standard laparoscopic prostatectomy [3] and then remote laparoscopic surgery using a master-slave manipulator, known as robot-assisted or robotic prostatectomy [4] , as alternatives to open surgery. In the USA there has been a predominantly direct transition from open to robotic prostatectomy, with 44% of procedures performed using the open technique and 53% using the robotic technique in 2008 [5] . By contrast, the European experience has been a transition from open to the standard laparoscopic technique followed, mainly in richer nations, by a second transition to the robot-assisted procedure; for example in the UK in 2012, 45% of procedures used the open, 26% the standard laparoscopic and 29% the robot-assisted techniques [2] .
Expert appraisal of the robotic technique suggests quicker surgeon learning and better ergonomics, although high cost of the robotic system remains a concern [6, 7] . When we started this work there were no high-quality direct comparative data from individual studies or meta-analyses available to decide between robot-assisted or standard laparoscopic prostatectomy as the better alternative to open surgery [8] . These data are needed as the robotic system may only be affordable if its use benefits individual patients and society in terms of better cancer control and quicker return to health. We aimed to address this by estimating differences in clinical outcomes between robotic and laparoscopic prostatectomy for men with localised prostate cancer using a mixed-treatment comparison meta-analysis. The work formed part of a Health Technology Assessment (HTA) commissioned by the UK Government which has been published as a monograph [9] .
Methods

Mapping a Care Pathway
A care pathway was defined for men undergoing robotic or laparoscopic prostatectomy as curative treatment for localised prostate cancer using published guidance [10, 11] and validated by consensus amongst an expert panel including patients and clinicians (Fig. 1) .
Systematic Literature Review
Eligibility criteria
We specified robotic prostatectomy as the intervention and laparoscopic prostatectomy as the comparator. We looked for reports of randomised control trials (RCTs) and non-randomised studies comparing outcomes specified in the Table S1 .
Study selection and data extraction
Titles and abstracts were screened and the full texts of potentially relevant reports were assessed for inclusion against pre-stated criteria by two reviewers, with a third acting as an arbiter. Data were extracted by three reviewers using a specifically designed form [9] . The reviewers checked each other's work for errors or inconsistencies. Diverse early harms of surgery were categorised using the Clavien-Dindo system by two surgeon reviewers independently, with a third acting as an arbiter [12] . Organ injury was categorised as Clavien IIIb as reporting of timing of repair was unclear. The method of pathological examination of the removed prostate in the included studies was assessed against the international consensus standard by a pathologist reviewer [13] . The quality of included full text English-language studies was assessed by three pairs of reviewers independently using the Cochrane risk of bias tool [14] [18] . ORs and their 95% credible intervals (CrIs) were estimated between robotic and laparoscopic prostatectomy for each outcome. An OR >1 shows that the event is more likely to occur after robotic prostatectomy whilst an OR <1 means that the event is more likely to occur after laparoscopic prostatectomy. The probability of each OR being different from 1 was calculated, values of P ≥ 0.95 being considered to indicate statistical significance. Finally, an individual estimate of the probability of the event occurring for each surgical technique was calculated using a prior distribution for the probability of occurrence with open radical prostatectomy and combining that with the OR between robotic and laparoscopic prostatectomy. The prior distribution was estimated by applying a normal distribution to the log odds of the probability of each outcome and using the standard Bayesian random effects model to calculate its mean and variance. As a sensitivity analysis the statistical models were run using data only from studies categorised as having a low risk of bias. In addition, for surgical margins, we intended to explore heterogeneity of effects by analysing only data from studies that reported all key pathological data. Vague prior distributions were used on the logarithm of the ORs of robotic and laparoscopic techniques vs open surgery, the individual study event rates, and the random effects SD. To assess publication bias, a funnel plot was constructed for included direct comparisons reporting the positive margin outcome. For most outcomes a burn-in period of 20 000 iterations was adequate to achieve convergence, although a further 100 000 samples were taken for each outcome.
The effect of surgeon learning on outcome was assessed by categorizing previous experience of participating surgeons and plotting this against the positive margin rate. In addition, data on starting level of expertise, rate of learning and defined expert level were extracted and meta-analysed using a random effects model to estimate pooled effect and associated uncertainty expressed as 95% CI.
Results
Details of Included Studies
We 
Quality Assessment
Overall assessment of risk of bias
The risk of bias was assessed for 48 studies and summary results for each outcome across the assessed domains are shown in Fig. 4 , with study level assessment in Fig. S4 . A total of 24 reports (50%) were categorised as having a high overall risk of bias, 13 (27%) as having a low risk and for 11 (23%) the risk of bias was rated unclear. The single identified RCT was judged to be at low risk of bias for sequence generation [S1]
and one further study was judged to be at low risk of bias for allocation concealment [S2]; all other studies were at high risk of bias or unclear for these two key domains. Funnel plot analysis including the six studies directly comparing robotic with laparoscopic prostatectomy and reporting positive margin outcome did not suggest publication bias (Fig. 5 ).
Outcome level assessment for risk of bias
Of the 37 studies reporting positive margin rates or cancer recurrence, 30 (81%) were considered to be at low risk of bias for confounding. Of the studies reporting urinary and sexual function outcomes, 12/23 (52%) and 10/20 (50%), respectively, were at low risk of bias for blinding and 9/23 (39.1%) and 9/20 (45%), respectively, were at low risk for incomplete outcome data.
Meta-analysis
The results of the meta-analysis are summarised in Table 3 and Fig. 6 . The positive surgical margin rate was significantly lower for robotic (18%) than for laparoscopic prostatectomy (24%) with an OR (95% CrI) of 0.69 (0.51 to 0.96), P = 0.99. Uncertainty surrounding this estimate was increased when only studies with a low risk of bias were analysed with the CrI, including the finding of no difference; OR (95% CrI) of 0.73 (0.29 to 1.75), P = 0.78 (Table 4 [S1, S13, S16, S19, S21-S23, S25, S29-S33, S36-S40, S42, S44, S45, S47, S49, S50, S52-S57, S60, S62-S64, S66-S68]). Methods of pathological analysis reported by included studies showed high variability and non-compliance with recommended protocols, with no two studies reporting the same method for ascertainment of positive margin status. It was therefore not possible to undertake the planned sensitivity analysis restricted to studies using a standard method. Duration of surgery was, on average, 12 min shorter for the robotic procedure (P = 0.99) but differing definitions made accuracy of this result highly uncertain. Men had a lower risk of major harms occurring during or immediately after robotic prostatectomy, such as injury to adjacent organs and leakage from the vesico-urethral anastomosis, but these events were uncommon. Other outcomes, including risk of biochemical recurrence at 12 months and rates of urinary incontinence, showed no Systematic review and comparative meta-analysis of outcomes from robotic and laparoscopic prostatatectomy difference. Rates of these outcomes reported by individual studies are given in Table S1 . We were unable to perform a meta-analysis for a number of pre-specified outcomes, such as sexual function and those describing patient experience, mainly owing to a lack of data and the use of widely varying outcome measurement tools (Table 5) .
Learning Curve
We used positive surgical margin rate as the key outcome to assess the effect of increasing surgeon experience in line with the main meta-analysis. In general, available data assessing surgeon learning was limited and often not in a form suited to meta-analysis with variable descriptive categorisation of surgeon prior experience. Regression modelling using data from studies included in the main meta-analysis showed no evidence of outcome trends with increasing experience (R 2 < 0.02%; Fig. 7 ). Extending study eligibility criteria to include case series identified four reports of robotic prostatectomy [S3-S6] and six reports of laparoscopic prostatectomy (Table 6 ) [S7-S12]. Two studies [S7,S9] only reported a mathematical shape to the learning curve, preventing extraction of relevant variables. All studies reported a decrease in positive surgical margin rates with increasing surgeon experience except one [S7], which reported a constant low rate for laparoscopic prostatectomy. The mean positive margin rates for both procedures fell from 26% at case one to 15% by case 250, and to 12% by case 1000. There was no evidence that this observed rate of learning differed between robotic and laparoscopic procedures with a mean (95% CI) difference of −0.02 [(−0.16 to 0.12), P = 0.76].
Discussion
Our mixed-treatment comparison meta-analysis made best use of the available, predominantly non-randomised comparative data to estimate the relative benefits and harms of robotic and laparoscopic prostatectomy as alternatives to open surgery. Imprecision and uncertainty surrounding these estimates mean that our findings should be interpreted cautiously. The significant reduction in the rate of a surgical margin positive for cancer after robotic prostatectomy is important since it is likely to be linked to a lower risk of disease recurrence and the need for further cancer treatment in the longer term [19] ; however, the limited data from included studies did not suggest lower rates of biochemical (PSA) cancer recurrence after robotic prostatectomy. The lower risk of major harms during and immediately after robotic prostatectomy suggests a superior safety profile, although these events were infrequent. There was no evidence of lower rates of urinary incontinence but we could not draw any conclusions about sexual dysfunction because of a lack of usable data. There was no evidence to suggest that surgeon learning rates were faster using the robotic system, although data were limited. The relative effects on patient experience and cancer-free survival remain unknown. Overall, we found no evidence that robotic prostatectomy was inferior to standard laparoscopic prostatectomy for treatment of men with localised prostate cancer.
We pre-defined the search strategy and outcomes of interest and used systematic, exhaustive search and data extraction techniques to ensure that all available data were identified and included in our meta-analysis. We may have missed usable data, although communication with authors of studies where fulfilment of our inclusion criteria was uncertain showed that only one of these studies was suitable. We specified a cut-off date for our search of 31 st October 2010 to allow time and resources for data extraction, risk of bias assessment and meta-analysis which underpinned the completion of a careful and high-quality evidence review. We performed an updated search of literature published between November 2010 and December 2011 identifying a further 15 comparative studies meeting our inclusion criteria, including one RCT which found as a secondary outcome a positive margin rate of 6/60 (10%) after laparoscopic prostatectomy and 8/52 (15%) after robotic prostatectomy [20] . We chose to exclude case series since meta-analysis of such studies are more likely to introduce selection bias stemming from lack of control of patient profiles across different societies and institutions. They are also less likely to address key outcomes, and are wasteful of research resources [21] . Personal and disease characteristics for included men were equivalent between the two procedures and reflected those of men undergoing radical prostatectomy in the UK [22] , suggesting that our findings were reliable and generalisable, and that potential confounders such as preoperative PSA value and Gleason score were balanced. To address confounding by disease stage, we excluded studies involving >10% of men with locally advanced (cT3) disease, as their greater risk of positive margin and disease persistence would have a disproportionate effect on outcomes if there was imbalance between study groups. This appeared effective since >80% of included studies contributing to positive margin outcome were categorised as at low risk of confounder bias. We made concerted efforts to prevent the inclusion of duplicate data resulting from multiple reports of the same cohort but it is possible that some instances were missed. Included studies were generally of low quality and data too few for meta-analysis of some important 0  100  200  300  400  500  600  700  800  900  1000  1100  1200  1300  1400  1500 Experience (number of procedures in study)
outcomes including sexual function, postoperative pain, and quality of life.
We included studies that used either contemporaneous or sequential comparative cohorts since we considered that such differences in design would not result in a particular direction of bias but rather that the overall quality of each included study was of greater importance [23] . An additional factor for this review was the likelihood that surgeons had less experience with the newer technique than the previous technique with which it was compared. Four of the eight robotic vs laparoscopic comparisons gave descriptive information on this issue with all stating that the surgeons were experienced in laparoscopic prostatectomy and had completed a structured training in robotic prostatectomy [S13-S16]. Publication bias for direct comparisons of the newer technique (robotic) against the alternative (laparoscopic) might be expected in the early phase of technology assessment which may be driven by individual surgeon enthusiasm or commercial pressures, but a restricted funnel plot analysis did not suggest such bias for reporting of positive surgical margins in line with previous reviews [24] [25] [26] .
Included studies were of short duration and data regarding disease-free survival were not available. A pathological finding of a surgical margin positive for cancer was therefore used as the measure by which to judge relative effectiveness. Achievement of a negative margin is considered to be an immediate marker of successful surgery, both in terms of cancer control and surgical quality, as a positive margin increases the risk of disease recurrence and the need for further cancer treatment [27, 28] . It is possible that variability and lack of consistency in the reporting of pathological examination techniques led to a systematic bias in the detection of positive margins, in particular for studies using a non-contemporary control group, but we found insufficient data to assess this. We chose not to re-analyse positive margin rate according to pathological stage given our limited inclusion of men with cT3 disease and concerns regarding analysis of sub-groups defined by non-baseline characteristics.
In line with best practice and to encompass all the factors described above, we individually assessed each included study for risk of bias using an established tool and multiple independent raters [14] . The positive margin re-analysis using low risk of bias study data showed a similar point estimate of effect but increased the degree of uncertainty to include the finding of no difference. For organ injury, the result showed an increased likelihood that robotic prostatectomy was safer with less uncertainty. For other outcomes, low risk of bias studies were too few for meaningful meta-analysis. Although the main limiting factor for these sensitivity analyses was low study quality there may also be inadequacies of the tool used [23] and the findings reinforce the need for methodological research [29] .
We identified four further systematic reviews and one published as three papers, contemporary to our own which used different meta-analytic techniques [24, 26, [30] [31] [32] [33] . All five reviews found that positive margin rate was the only cancer outcome with sufficient data for meta-analysis and, although central estimates of risk all favoured robotic prostatectomy, effect size and degree of uncertainty varied, with only our results and those of Tewari et al. [26] showing statistical significance (Table 7 [ 24, 26, [30] [31] [32] [33] ). The aim of any meta-analysis is to calculate the most accurate and precise estimate of the true absolute or relative value for any outcome from the data deemed eligible for inclusion. It continues to be a challenge to achieve this without high-quality randomised controlled data and a number of statistical models have evolved to make use of non-randomised data with reduced uncertainty. We considered that a mixed-treatment comparison including indirect comparisons was the most appropriate model, in line with guidance from evidence-synthesis organisations [14, [34] [35] [36] [37] . This achieved a large sample size whilst maintaining the advantage of estimation of outcomes as relative differences rather than crude absolute rates to minimise effects of selection and reporting bias. The method also captured different transitions of surgeon experience, such as that from open to robotic prostatectomy and open to laparoscopic to robotic, and avoided procedural bias that could arise from only including publications from centres able to perform both robotic and laparoscopic techniques. For positive margin outcome, random effects meta-analyses using only direct comparative studies all gave broadly similar results but had small total sample size which varied according to different judgements on study eligibility [24, [30] [31] [32] [33] (Fig. 7) . Tewari et al. [26] expanded total sample size further by including case series of both techniques and used propensity-matching to control for differences in baseline characteristics. Whilst this gave a more precise estimate of difference in positive margin rate it may [21, 29, 38] . In terms of other outcomes we reported comparative data for individual complications specifically recorded in the source material, whilst in the other studies they were grouped together using varying criteria preventing any comment of the relative accuracy of estimates. One review found a significantly higher rate of continence for robot-assisted than for standard laparoscopic prostatectomy at 1 year [30] , whilst the other three studies reporting this outcome, including our own, found no evidence of a differential risk between the two procedures [24, 26] ; this may have resulted from varying study inclusion criteria. For the seeker of evidence, these five meta-analyses can be thought of as sensitivity analyses exploring the impact of different methodological judgments. The consistency in the direction of relative difference in positive margin rate and the lack of any outcomes assessed as inferior after robotic prostatectomy across the studies are reassuring, but interpretation of any meta-analysis based on non-randomised data should always be cautious [29] .
Our finding of no evidence for differential surgeon learning between the two techniques differs from other publications [39] . This may be attributable to the use of positive margin rates rather than operating time or blood transfusion rates as a competency marker or possibly to the limited nature of the data available. Our results suggest that the individual surgeon's rate of learning is the dominant factor rather than the technology used [40] .
The need for radical prostatectomy is likely to be maintained or to increase over the next 5 years with PSA-driven higher detection rates for localised prostate cancer, although new less invasive treatments may expand the choice of management [41] . Our results will help guide patients, clinicians and healthcare managers in the choices they make regarding the implementation and use of robotic prostatectomy but, given uncertainty around the meaning of the data, cautious interpretation is emphasised and other sources of evidence, particularly contemporary meta-analyses should be considered. It seems unlikely that a large robustly designed RCT comparing robotic with laparoscopic prostatectomy will be carried out (a feasibility study was recently unsuccessful in the UK) but well-designed prospective multicentre cohort studies with longer-term outcome assessment as well as independent verification of baseline data and outcome should be possible. Without such studies assessment of the value of costly new technology to patients and healthcare systems such as the UK NHS will continue to be imperfect.
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